Experiments in primary islets reveal -arrestin1 limits the insulin response to GLP-1, but not GIP or tirzepatide, suggesting that the biased agonism of tirzepatide enhances insulin secretion
Browse GLP-1 molecules GLP Weight Loss Results Interactive charts showing weight-change patterns observed in clinical trials (educational, not a prediction)
Overweight and obesity, in particular, intra-abdominal adiposity, are associated with various cardiometabolic conditions including type 2 diabetes (T2D), dyslipidemia, hypertension, atherosclerotic cardiovascular disease, and heart failure [2, 3]
As various behaviors are rewarded with the release of dopamine, we want to repeat those behaviors
Severe Gastrointestinal Disease: Those with gastroparesis (slow stomach emptying) must be extremely careful with how they time their doses
These schedules summarise published clinical research design and are not instructions for use of this product